Company Intelligence
Ditto Biosciences
Ditto Biosciences provides enterprise-grade artificial intelligence solutions, delivering specialized Evolutionary intelligence for autoimmune disease technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
- Headquarters
- San Francisco, United States
- Website
- www.dittobio.com
- Founded
- 2026
- Stage
- Early
- Status
- Active
- Products
- 1
- Reports
- 8
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
Ditto Biosciences is a Healthcare AI company based in San Francisco, United States, founded in 2026.
Ditto Biosciences develops evolutionary intelligence for autoimmune disease.
What it builds
Evolutionary intelligence for autoimmune disease
Why It Matters
Ditto Biosciences provides enterprise-grade artificial intelligence solutions, delivering specialized Evolutionary intelligence for autoimmune disease technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
Products
Products and platforms connected to this company.
-
Ditto Biosciences
Explore Ditto Biosciences by Ditto Biosciences. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical architecture,…
View product intelligence
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
Ditto Biosciences
Industry
Products
Capabilities
- Evolutionary intelligence for autoimmune disease
Features
- Evolutionary intelligence for autoimmune disease
Country
Official Resources
Official and developer links on file for this company.
Frequently Asked Questions
What does Ditto Biosciences do?
Ditto Biosciences specializes in artificial intelligence, developing Evolutionary intelligence for autoimmune disease to support enterprise software developers and digital transformation teams with scalable, production-grade technology.
Where is Ditto Biosciences based and when was it founded?
Ditto Biosciences is based in United States and was founded in 2026.
What are the main products offered by Ditto Biosciences?
The flagship platform from Ditto Biosciences is Evolutionary intelligence for autoimmune disease, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of Ditto Biosciences?
Ditto Biosciences primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Primary sources
Request a correction if you represent this company or believe information is inaccurate.